← Back to all trials
Recruiting
NCT05605145
PCP in Immunocompromised Population in Southern China
Conditions: Immunocompromised Patients, Pneumocystis Pneumonia, Diagnosis, Polymerase Chain Reaction
Sex: All
Enrollment: 300
Sponsor: First Affiliated Hospital of Guangxi Medical University
Location: China
Summary
To evaluate the sensitivity and specificity of the combined detection system for the diagnosis of pneumocystis infection in immunocompromised population in Southern China.
Eligibility Criteria
Inclusion Criteria:Patients with immunocompromised conditions, including but not limited to HIV infection, long-term systemic use of corticosteroids, use of immunosuppressive agents, hematologic malignancies, solid tumors, hematopoietic stem cell transplantation, solid organ transplantation, radiotherapy and/or chemotherapy for malignancies,primary immunodeficiency disease.Patients with typical clinical manifestations of PJP such as fever,nonproductive cough, shortness of breath, and progressive hypoxemia.Patients with radiological abnormalities suggestive to PJP in bilateral lungs revealed by chest computed tomography (CT).Respiratory tract samples were collected for qPCR and/or mNGS detection.Exclusion Criteria:Patients who were unable to obtain a respiratory specimen.Medical record was incomplete.
Source: ClinicalTrials.gov (NCT05605145). StuddyBuddy aggregates publicly available trial information.